Mandate

Investor Growth Capital new principle owner in Doxa

July 19, 2006

Through a special issue of shares, Investor Growth Capital will become the principle owner of the Uppsala-based medical technology company Doxa. Doxa develops new biomaterial for medical use. Since 2002, work has concentrated on rapidly growing field of orthopaedics. The infusion of capital will finance continued development of their biomaterial.

Vinge acted as advisor to Investor Growth Capital. Vinge representatives included Johan Winnerblad and Tom Zachrisson.

Related

Vinge has advised Montrose by Carnegie AB on its application for authorisation to conduct securities business

Vinge has successfully advised Montrose by Carnegie AB in connection with its application to the Swedish Financial Supervisory Authority for authorisation to conduct securities business. The authorisation was granted by the Swedish Financial Supervisory Authority on 2 July 2026.
August 12, 2026

Vinge advises Mjällby AIF on the transfer of Elliot Stroud to Hull City AFC

Vinge has advised reigning Allsvenskan champions Mjällby AIF in connection with the transfer of Swedish international Elliot Stroud to Premier League club Hull City AFC.
August 10, 2026

Vinge advises Altor on its public offer for Sleep Cycle

Snark BidCo, a company controlled by Altor Fund V (No. 1) and Altor Fund V (No. 2) announced a public offer to the shareholders of Sleep Cycle AB to tender all their shares to Snark BidCo. The shares in Sleep Cycle are admitted to trading on Nasdaq Stockholm. After the end of the extended acceptance period, Snark BidCo controls approximately 79.2 percent of the share capital and votes in Sleep Cycle. The total value of the offer was approximately SEK 497 million.
August 07, 2026